All News
A Rheumatology State of Mind (Best of 2015)
A 2013 study reported that people from Denmark were the happiest. Reasons were postulated, but it was suggested it was because their expectations were so low.
Read Article
Physicians Bash Meaningful Use at Open Forum
Members of two professional medical societies griped about what they view as the Obama administration's inept attempts to regulate electronic health records (EHRs) and shared their visions for the ideal online platform at a second "town hall" meeting here Tuesday.
Read Article
Top 5 and Bottom 5 Joints (Best of 2015)
Who knows or ponders the articulations (joints) more so than the rheumatologist or orthopedist? We know their anatomy, their contours, tender sites and how to examine them. Adults have over 200 bones and up to 360 joints. Imagine if you had to do a DAS360?
Read Article
The Differential Diagnosis of Heel Pain (Best of 2015)
A slim, yoga bending, middle aged school teacher seeks a rheumatology consultation to determine the cause and cure for her left lateral heel pain for the past 6 months. No trauma, no crazy footwear and no systemic symptoms, uveitis, or peripheral/axial arthritis.
Read Article
Famous Rheumatologist Quotes – Part I (Best of 2015: #8)
A famous quote from Verna Wright, MD,states, “Clinicians may all too easily spend years writing“doing well” in the notes of a patient who has become progressively crippled before their eyes".
Read Article
Building a Better Rheumatologist (Best of 2015)
There’s a certain comfort to work that is rote, mechanistic and almost automatic.
Read Article
In Academic Leadership, Women Outnumbered by Men With Moustaches
A study published in the BMJ Christmas issue shows only 13% of academic positions at US medical schools are held by women. Sadly, and strangely, even the uncommon subset, men with moustaches, outnumbered (20%) the women in academic leadership spots.
Read Article
RA Guidelines, Methotrexate and Mortal Risks in Gout: November 2015 top social media news
Here's what you may have missed: in November 2015, RheumNow published 80 tweets on news, research and teaching points that impact the rheumatology community. We had a reach (impressions) of 79,100, 79 mentions, and over 3399 visits to RheumNow.com to check out what we publish.
Read Article
EULAR 2015 Psoriatic Arthritis Treatment Guidelines
The management of psoriatic disease, including psoriatic arthritis (PsA) has evolved significantly in the last decade. Nevertheless, there are still some uncertainties - such as what the role of methotrexate should be, and when to use newer and novel therapies.
Read Article
Famous Rheumatologist Quotes – Part I
A famous quote from Verna Wright, MD, states, “Clinicians may all too easily spend years writing“doing well” in the notes of a patient who has become progressively crippled before their eyes".
Read Article
Physician Burnout on the Rise
Burnout among U.S. doctors affects more than half of practicing physicians, according to a new study published in Mayo Clinic Proceedings. (Citation source http://buff.ly/1RpV8Q0)
Read Article
DSB: ACR 2015 Safety Reports
The following is a compilation of abstracts presented at the 2015 Annual ACR meeting in San Francisco. These were chosen on the basis of impact, quality and safety message.
Read Article
SB4 - A Second Biosimilar Up For Review in Europe
A biosimilar of etanercept (Enbrel) made by the South Korean company Samsung Bioepis is under consideration by regulators in the European Union. Samsung Bioepis, a joint venture between Samsung Biologics and Biogen, is taking aim with its version of etanercept.
Read Article
Tocilizumab & Abatacept Effective in Giant Cell Arteritis
Giant cell arteritis (GCA) is a medium and large vasculitis, wherein only glucocorticoids (GC) treatment has been the mainstay of therapy. As many will require prolonged treatment, the hazards of GC are well known, lead to substantial toxicity and morbidity.
Read Article
Are Guidelines Worth the Cost?
A thoughtful perspective on the purpose, focus and cost of guideline efforts in rheumatology has been published in the journal Rheumatology.
Anifrolumab Improves Lupus Outcomes
Furie and coworkers presented the results of a 52-week phase II trial of anifrolumab (ANIFR), a type I interfernon (IFN) receptor antagonist in patients with lupus (SLE).
Read Article
Western Diet Increased the Risk of Rheumatoid Arthritis
Liu and coworkers from Boston presented abstract #1213, with data from the NHS II Survey. They examined 93,859 women (without RA) and their dietary data from 1991 to 2011.
Read Article
Improving Cardiovascular Trends in Rheumatoid Arthritis
Myasoedova and colleagues from the Mayo Clinic have reported their new data that demonstrates improving cardiovascular (CV) mortality rates in current RA patients treated with modern drugs.
Read Article
